EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Increased Insulin Secretion and Glucose Effectiveness in Obese Patients with Type 2 Diabetes following Bariatric Surgery

Roberto Visentin iD, Katrine Brodersen iD, Bjørn Richelsen iD, Niels Møller iD, Chiara Dalla Man iD, Andreas Kristian Pedersen iD, Jan Abrahamsen iD, Jens Juul Holst iD, Michael Festersen Nielsen iD

Journal of Diabetes Research · 2023

DOI: 10.1155/2023/7127426 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Diabetes Research, 2023. Verfasst von Roberto Visentin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Information Engineering, University of Padova, Padova, Italy. Hauptthemen laut MEDLINE: Insulin Resistance, Diabetes Mellitus, Type 2, Bariatric Surgery, Gastric Bypass. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CEO Emil C. Hertz and Wife Inger Hertz’ Foundation, A. P. Moeller Foundation, Lippmann Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background. β-cell dysfunction and insulin resistance are the main mechanisms causing glucose intolerance in type 2 diabetes (T2D). Bariatric surgeries, i.e., sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB), are procedures both known to induce weight loss, increase insulin action, and enhance β-cell function, but hepatic insulin extraction and glucose effectiveness may also play a role.

Methods

To determine the contribution of these regulators on glucose tolerance after bariatric surgery, an oral glucose tolerance test (OGTT) was performed before and 2 months after surgery in 9 RYGB and 7 SG subjects. Eight healthy subjects served as metabolic controls. Plasma glucose, insulin, C-peptide, GLP-1, and GIP were measured during each OGTT. Insulin sensitivity and secretion, glucose effectiveness, and glucose rate of appearance were determined via oral minimal models.

Results

RYGB and SG resulted in similar weight reductions (13%, RYGB ( p < 0.01 ); 14%, SG ( p < 0.05 )). Two months after surgery, insulin secretion ( p < 0.05 ) and glucose effectiveness both improved equally in the two groups (11%, RYGB ( p < 0.01 ); 8%, SG ( p > 0.05 )), whereas insulin sensitivity remained virtually unaltered. Bariatric surgery resulted in a comparable increase in the GLP-1 response during the OGTT, whereas GIP concentrations remained unaltered. Following surgery, oral glucose intake resulted in a comparable increase in hepatic insulin extraction, the response in both RYGB and SG patients significantly exceeding the response observed in the control subjects.

Conclusions

These results demonstrate that the early improvement in glucose tolerance in obese T2D after RYGB and SG surgeries is attributable mainly to increased insulin secretion and glucose effectiveness, while insulin sensitivity seems to play only a minor role. This trial is registered with NCT02713555.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Insulin ResistanceDiabetes Mellitus, Type 2Bariatric SurgeryGastric BypassHumansGlucoseInsulin SecretionBlood GlucoseObesityInsulinGlucagon-Like Peptide 1Gastrectomy

Substanzen

GlucoseBlood GlucoseInsulinGlucagon-Like Peptide 1

Autor:innen und Institutionen

  • Department of Information Engineering, University of Padova, Padova, Italy.
  • Department of Surgery, Viborg General Hospital, Denmark.
  • Steno Diabetes Center Aarhus, Aarhus University Hospital & Clinical Medicine, Aarhus University, Denmark.
  • Department of Clinical Research, University Hospital of Southern Denmark, Denmark.
  • Department of Radiology, Viborg General Hospital, Denmark.
  • Novo Nordisk Foundation, Center of Basic Metabolic Research and Department of Biomedical Sciences, The Panum Institute, University of Copenhagen, Denmark.

ORCID-Profile: Roberto Visentin, Katrine Brodersen, Bjørn Richelsen, Niels Møller, Chiara Dalla Man, Andreas Kristian Pedersen, Jan Abrahamsen, Jens Juul Holst, Michael Festersen Nielsen

Förderung

  • CEO Emil C. Hertz and Wife Inger Hertz’ Foundation
  • A. P. Moeller Foundation
  • Lippmann Foundation
  • Toyota Foundation
  • Hartmann Foundation
  • M.Sc. Engineer Frode V. Nyegaard and Wife’s Foundation
  • Shipowner Per Henriksen, R. and Wife’s Foundation
  • Augustinus Foundation

Zitieren

APA

Visentin, R., Brodersen, K., Richelsen, B., Møller, N., Dalla Man, C., Pedersen, A. K., Abrahamsen, J., Holst, J. J., & Nielsen, M. F. (2023). Increased Insulin Secretion and Glucose Effectiveness in Obese Patients with Type 2 Diabetes following Bariatric Surgery. Journal of Diabetes Research. https://doi.org/10.1155/2023/7127426

Vancouver

Visentin R, Brodersen K, Richelsen B, Møller N, Dalla Man C, Pedersen AK, et al. Increased Insulin Secretion and Glucose Effectiveness in Obese Patients with Type 2 Diabetes following Bariatric Surgery. Journal of Diabetes Research. 2023. doi:10.1155/2023/7127426

BibTeX
@article{Visentin2023,
  author = {Visentin, Roberto and Brodersen, Katrine and Richelsen, Bjørn and Møller, Niels and Dalla Man, Chiara and Pedersen, Andreas Kristian and Abrahamsen, Jan and Holst, Jens Juul and Nielsen, Michael Festersen},
  title = {Increased Insulin Secretion and Glucose Effectiveness in Obese Patients with Type 2 Diabetes following Bariatric Surgery},
  journal = {Journal of Diabetes Research},
  year = {2023},
  doi = {10.1155/2023/7127426}
}
Kostenlos starten →